𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers

✍ Scribed by Richard S. Tedder; Samreen Ijaz; Nicola Gilbert; John A.J. Barbara; Sally A. Corden; Richard J.C. Gilson; Elizabeth H. Boxall


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
122 KB
Volume
68
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Anti‐hepatitis Be (HBe) carriers are perceived as having low infectivity, with hepatitis B virus (HBV) DNA levels far below those seen in the HBeAg carrier. However, the temporal stability of HBV DNA in anti‐HBe carriers remains poorly characterised. UK Department of Health guidelines use HBV DNA levels to define whether HBV‐infected health care workers may perform exposure‐prone procedures. Two samples separated by 1–23 years available from 147 carriers were analysed for precore variants and HBV DNA levels. Among 15 HBeAg carriers, HBV DNA was maintained at high levels. There was a 5 log~10~ fold reduction in DNA in 11 individuals who developed anti‐HBe during follow‐up evaluation. Proportional changes in HBV DNA levels in anti‐HBe carriers were similar to those in HBeAg carriers, although there was a trend for changes in viral DNA to be more marked in anti‐HBe carriers followed up for longer periods. Closer sampling in 20 anti‐HBe carriers demonstrated large fluctuations of DNA levels over short periods. Serum transaminases and precore mutant status at the outset failed to predict those in whom HBV DNA levels fluctuated. HBV DNA was below the detection threshold (<400 copies/ml) in 36 anti‐HBe carriers at first sampling and remained so in all but 5 of these carriers. Twelve individuals who were previously viraemic lost detectable HBV DNA during follow‐up evaluation. While HBV DNA levels are found to fluctuate in carriers, our results indicate that once below the threshold of detectability, levels are unlikely to rise. This is an important factor when assessing health care workers for exposure‐prone procedures. J. Med. Virol. 68:505–512, 2002. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Hepatitis B virus C gene heterogeneity i
✍ G. Fiordalisi; D. Primi; E. Tanzi; E. Magni; C. Incarbone; A. R. Zanetti; E. Car 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

## Abstract We studied a familial cluster of adult HBV chronic carriers characterized by serological markers of active viral replication, normal or slightly elevated ALT levels and, in four out of five cases, absence of anti‐HBc reactivity. The nucleotide sequence of the pre‐C/C region of HBV was a

Is there a meaningful serum hepatitis B
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Ioannis S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

The diagnosis of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B indicating therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA >2,000 IU/mL. We evaluated the severity of liver histology and the presence of histological indication for treatment in patients with H

Fulminant hepatitis in patients undergoi
✍ Ferraz, M. Lucia ;Silva, A. Eduardo ;Macdonald, Graeme A. ;Tsarev, Sergei A. ;Di 📂 Article 📅 1996 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 596 KB

Fulminant hepatic failure (FHF) in the absence of serum markers of hepatitis A (HAV) or B (HBV) infection or another cause is called non-A, non-B (NANB) FHF. The pathogenetic role of viral infection in NANB FHF remains controversial. To better define this relationship, we studied patients who underw

Novel application of a point mutation as
✍ A. E. Hawkins; Dr R. J. C. Gilson; S. V. Beath; E. H. Boxall; D. A. Kelly; R. S. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 801 KB

## Abstract Mutations of the precore region of hepatitis B virus (HBV) genome have been associated with fulminant and severe chronic hepatitis. However uncertainty remains about the clinical significance and transmissibility of these mutant strains. A point mutation assay (PMA) was developed to ide

Hepatocellular carcinoma in alcoholic li
✍ Eike Walter; Hubert E. Blum; Peter Meier; Martin Huonker; Martin Schmid; Klaus-P 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 3 views

Hepatocellular carcinoma tissues from HBsAg-negative patients with chronic alcoholic liver disease were investigated for the presence of hepatitis B virus DNA. Southern blot analyses of DNA extracted from the hepatocellular carcinomas were negative for hepatitis B virus DNA in all 17 patients examin